Target intelligence / Profile preview

Lymph node reticular cell network (FRC network)

Target
FRC network
Molecular classification
Other
01

Overview

The lymph node reticular cell network is a specialized stromal framework composed of fibroblastic reticular cells (FRCs) and extracellular matrix components that organize the internal architecture of the lymph node. This network functions as a physical scaffold for immune cell migration and a conduit system for the rapid transport of lymph-borne small molecules, such as antigens and chemokines, to the T-cell zone (Acton et al., 2014, Nature Reviews Immunology). FRCs within the network are vital for immune homeostasis, as they secrete key chemokines (CCL19, CCL21) and survival factors (IL-7) that regulate the positioning and survival of T cells and dendritic cells (Link et al., 2007, Nature Immunology). In pathological conditions, the reticular network undergoes significant remodeling; for example, chronic inflammation or viral infections like HIV can lead to network fibrosis, which impairs immune reconstitution (Schacker et al., 2002, Journal of Clinical Investigation). Furthermore, the network is often exploited by metastatic cancer cells to facilitate their entry and survival within the lymph node (Lund & Swartz, 2010, Nature Reviews Cancer). While the network itself is a multicellular structure rather than a single drug target, specific molecular components such as podoplanin or chemokine receptors are targeted to modulate immune responses or inhibit metastasis.

Other names
Fibroblastic reticular cell networkLymphoid stromal networkLymph node conduit systemLymph node stromaFRC network
02

Mechanism of action

Not applicable for a multicellular structure; however, therapeutic interventions may target specific molecular components of the network to modulate immune cell recruitment or prevent fibrosis.

03

Biological functions

Immune responseCell traffickingStructural supportAntigen transportCytokine signaling
04

Disease associations

CancerInfectionInflammationFibrosis
05

Safety considerations

Impaired immune surveillanceLymphedemaIncreased susceptibility to infectionDisruption of homeostatic T-cell maintenance
06

Biomarkers

Podoplanin (gp38)CCL21CCL19Alpha-smooth muscle actin (α-SMA)DesminVimentin

Beyond the preview

Go deeper on Lymph node reticular cell network (FRC network).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymph node reticular cell network (FRC network).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call